Pharmaceuticals is the largest segment driving the growth of Bacillus Coagulans Market

Comments · 4 Views

The Bacillus Coagulans Market is estimated to be valued at US$ 722.43 Mn in 2023 and is expected to exhibit a CAGR of 6.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Bacillus coagulans is a type of bacteria that occurs naturally in the digestive system, intestines, and mucus membrane. It helps regulate digestive health and immunity. Bacillus coagulans products are available in the form of powders, capsules, and tablets. These probiotic supplements support digestive health, balance gut microbiota, aid nutrient absorption, and boost immune function. With changing lifestyles and rising health issues, demand for natural remedies and supplements is increasing significantly.

Market key trends:

One of the major trends fueling market growth is the rising consumer focus on health and wellness. There is increasing awareness about the role of probiotics in maintaining overall well-being. Studies show that regular probiotic intake through supplements supports digestive health, reduces risks of diarrhea, irritable bowel syndrome, and other gastrointestinal disorders. Additionally, probiotics modulate immunity and reduce occurrence of respiratory infections. Many consumers thus rely on Bacillus coagulans supplements to fulfill their daily probiotic requirements. This growing consumer preference for natural remedies over medications is propelling the demand for Bacillus coagulans products. Manufacturers are launching novel formulations targeting specific health benefits to further boost the market potential.

Porter's Analysis

Threat of new entrants: The threat of new entrants in the Bacillus Coagulans market is moderate as setting up a new manufacturing plant requires high capital investments and obtaining regulatory approvals.

Bargaining power of buyers: The bargaining power of buyers is high as Bacillus Coagulans has applications in various end-use industries like food and beverages, pharmaceuticals, and personal care. Buyers can negotiate lower prices due to availability of substitutes.

Bargaining power of suppliers: The bargaining power of suppliers is moderate as key raw materials for Bacillus Coagulans are commoditized which limits suppliers' power over buyers.

Threat of new substitutes: The threat of new substitutes is moderate as researchers are exploring new probiotic strains with better functionality.

Competitive rivalry: High due to presence of numerous domestic and global players.

SWOT Analysis

Strength: Bacillus Coagulans is stable throughout processing and production of probiotic products. It survives passage through stomach acid and bile salts which allows it to support healthy gut microflora.

Weakness: High R&D costs associated with developing new Bacillus Coagulans strains. Changes in regulatory approvals pose risks.

Opportunity: Growth in functional food and beverages industry drives demand. Rising health awareness boosts probiotic supplements market. Emerging markets offer immense potential.

Threats: Stringent safety and quality regulations may increase compliance costs. Economic slowdownscan impact demand.

Key Takeaways

The global Bacillus Coagulans market is expected to witness high growth, exhibiting CAGR of 6.8% over the forecast period, due to increasing consumer preference for healthy and preventive healthcare. The food and beverages application segment dominates currently due to wide usage of Bacillus Coagulans in dairy products, baked goods, cereals, and snacks.

Regionally, North America holds the major share in the Bacillus Coagulansmarket owing to rising health consciousness. Asia Pacific is expected to be the fastest growing market due to growing middle class population, increasing per capita income, and rising health expenditure.

Key players operating in the Bacillus Coagulans market are Ganeden, Sabinsa Corporation, UAS Laboratories, Sanzyme, Mitsubishi Chemical Foods Corporation, Mystical Biotech Pvt. Ltd., Aumgene Biosciences, Unique Biotech Ltd., Nebraska Culture, and Syngem Biotech.

 

Read More

https://www.ukwebwire.com/bacillus-coagulans-market-size-share-growth-outlook-2023/

disclaimer
Read more
Comments